Ross, David M <br/><br/>
Reverse transcription with random pentadecamer primers improves the detection limit of a quantitative PCR assay for BCR-ABL transcripts in chronic myeloid leukemia: implications for defining sensitivity in minimal residual disease.  [electronic resource] 

 -  Clinical chemistry  Sep 2008 
 - 1568-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-8561 
<br/><br/><label>Standard No.: </label>10.1373/clinchem.2008.105916  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>DNA Primers--analysis<br/>Fusion Proteins, bcr-abl--analysis<br/>Humans<br/>Leukemia, Myeloid, Chronic-Phase--diagnosis<br/>Neoplasm, Residual--diagnosis<br/>Reverse Transcriptase Polymerase Chain Reaction--methods<br/>Sensitivity and Specificity<br/>Transcription, Genetic--genetics